XLH UK XLH UK XLH UK
Menu
close
  • What is XLH and more
  • Treatment
    • Treatment
    • Dentistry
    • Resources
  • Genetics
  • Latest News
  • Contact Us
  • The Work We Do
    • Supporter Events
    • Events
    • About Us
    • XLH UK policy on working with pharmaceutical and medical device companies
    • Privacy Policy
Donate
Donate
Post List
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout point of using.
Home Post List
Post List

Modern Style

October 23, 2020 Webinar on the unrecognised burden of XLH in adults
September 24, 2020
XLH UK features in the New Scientist magazine
NHS Scotland logo
February 10, 2020
Scottish Medicines Consortium enables access to burosumab for treating X-linked hypophosphataemia
October 13, 2019
Help those in Scotland and Ireland access new treatment
January 18, 2019
NICE u-turn approves first therapy for children with XLH
Post List

Creative Style

October 23, 2020
Webinar on the unrecognised burden of XLH in adults
September 24, 2020
XLH UK features in the New Scientist magazine
NHS Scotland logo
February 10, 2020
Scottish Medicines Consortium enables access to burosumab for treating X-linked hypophosphataemia
October 13, 2019
Help those in Scotland and Ireland access new treatment
January 18, 2019
NICE u-turn approves first therapy for children with XLH
December 21, 2018
James Lind Alliance Rare Musculoskeletal Diseases PSP
June 6, 2018
Westminster Parliamentary Reception
June 1, 2018
ECTS 2018 report
Post List

Numbered Posts Style

XLH UK
A Charitable Trust
The mission of XLH UK is to promote XLH and related disorders, awareness and education for affected families, medical professionals, and the community at-large within the UK
XLH UK © 2020. Registered Charity (England and Wales) 1182964.   This information should not serve as medical advice or instruction. Please always consult your healthcare professional in the first instance.